Progastrin-releasing peptide: Stability in plasma/serum and upper reference limit

Tumor Biology

Volumn 29, Issue 3, 2008, Pages 204-210

  Nordlund, Marianne S ^a   Bjerner, Johan ^a   Warren, David J ^a   Nustad, Kjell ^a   Paus, Elisabeth ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Carcinoma, small cell; Gastrointestinal hormones; Immunoassay; Progastrin releasing peptide; Protease inhibitors; Tumor markers

Indexed keywords

ANTICOAGULANT AGENT; CREATININE; EDETIC ACID; PROGASTRIN RELEASING PEPTIDE; PROTEINASE INHIBITOR; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MALE; PHYSICAL ACTIVITY; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN STABILITY; REFERENCE VALUE; ROOM TEMPERATURE; SERUM; SEX; SMOKING;

EID: 48049088329     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000148188     Document Type: Article

References (17)

1. Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K: Pro-gastrin-releasing peptide (ProGRP) - a useful marker in small cell lung carcinomas. Anticancer Res 1999;19:2673-2678.
2. McDonald TJ, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V: A gastrin releasing peptide from the porcine nonantral gastric tissue. Gut 1978;19:767-774.
3. Molina R, Filella X, Auge JM: ProGRP: a new biomarker for small cell lung cancer. Clin Biochem 2004;37:505-511.
4. Miyake Y, Kodama T, Yamaguchi K: Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994;54:2136-2140.
5. Takada M, Kusunoki Y, Masuda N, Matui K, Yana T, Ushijima S, Iida K, Tamura K, Komiya T, Kawase I, Kikui N, Morino H, Fukuoka M: Pro-gastrin- releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase. Br J Cancer 1996;73:1227-1232.
6. Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R, Kodama T: Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lung Cancer 2000;27:159-167.
7. Lamy P, Grenier J, Kramar A, Pujol JL: Progastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer 2000;29:197-203.
8. Molina R, Auge JM, Filella X, Vinolas N, Alicarte J, Domingo JM, Ballesta AM: Progastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Anticancer Res 2005;25:1773-1778.
9. Nordlund MS, Fermer C, Nilsson O, Warren DJ, Paus E: Production and characterization of monoclonal antibodies for immunoassay of the lung cancer marker proGRP. Tumour Biol 2007;28:100-110.
10. Nordlund MS, Warren DJ, Nustad K, Bjerner J, Paus E: Automated time-resolved immunofluorometric assay for progastrin-releasing peptide. Clin Chem 2008;54:919-922.
11. Rustad P, Simonsson P, Felding P, Pedersen M: Nordic Reference Interval Project Biobank and Database (NOBIDA): a source for future estimation and retrospective evaluation of reference intervals. Scand J Clin Lab Invest 2004;64:431-438.
12. Pedersen MM, Rustad P, Simonsson P: Certificate of analysis NFKK reference serum X: a reprint. Scand J Clin Lab Invest 2004;64:321-326.
13. R Development Core Team: R: a language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2007. http://www.r-project.org.
14. Bjerner J: Age-dependent biochemical quantities: an approach for calculating reference intervals. Scand J Clin Lab Invest 2007;67:707-722.
15. Yoshimura T, Fujita K, Kawakami S, Kitahara M, Dowell B: Stability of pro-gastrin releasing peptide in serum and plasma. Tumor Biol 2007;28(suppl 1):109.
16. Nakahama H, Tanaka Y, Fujita Y, Fujii M, Sugita M: CYFRA 21-1 and ProGRP, tumor markers of lung cancer, are elevated in chronic renal failure patients. Respirology 1998;3:207-210.
17. Molina R, Auge JM, Alicarte J, Filella X, Vinolas N, Ballesta AM: Pro-gastrin-releasing peptide in patients with benign and malignant diseases. Tumour Biol 2004;25:56-61.